Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Brain structural correlates of an impending initial major depressive episode
    Published on 2025-03-11
    1 year ago
  • Paternal heroin self-administration in rats increases drug-seeking behavior in male offspring via miR-19b downregulation in the nucleus accumbens
    Published on 2025-03-07
    1 year ago
  • IN MEMORIAM: Floyd E. Bloom, M.D
    Published on 2025-03-04
    1 year ago
  • Persistent brain network signatures in psychosis: implications for diagnosis, prognosis, and treatment
    Published on 2025-03-04
    1 year ago
  • Central Executive Network drives delta-9-tetrahydrocannabinol (THC)-induced nonlinear changes in large-scale functional connectivity in adolescent nonhuman primates
    Published on 2025-02-27
    1 year ago
  • A new module in the drug development process: preclinical multi-center randomized controlled trial of R-ketamine on alcohol relapse
    Published on 2025-02-27
    1 year ago
  • The crosstalk between CREB and PER2 mediates the transition between mania- and depression-like behavior
    Published on 2025-02-26
    1 year ago
« Previous 1 … 60 61 62 63 64 … 143 Next »
Journal of Psychopharmacology
  • Ketamine: A new chapter for clinical psychopharmacology?
    Published on 2023-08-01
    3 years ago
  • Improving Translational Relevance in Preclinical Psychopharmacology (iTRIPP)
    Published on 2023-07-31
    3 years ago
  • Associations between regular cannabis use and brain resting-state functional connectivity in adolescents and adults
    Published on 2023-07-29
    3 years ago
  • Hippocampal phase precession is preserved under ketamine, but the range of precession across a theta cycle is reduced
    Published on 2023-07-29
    3 years ago
  • Postpartum psychosis: A proposed treatment algorithm
    Published on 2023-07-29
    3 years ago
  • Association of cannabis use with neurocognition in adolescents with bipolar disorder
    Published on 2023-07-27
    3 years ago
  • Ketamine-induced changes in resting state connectivity, 2 h after the drug administration in patients with remitted depression
    Published on 2023-07-26
    3 years ago
« Previous 1 … 60 61 62 63 64 … 150 Next »
European Neuropsychopharmacology
  • Clozapine dosing patterns and clinical outcomes in patients with treatment resistant schizophrenia
    Published on 2023-08-07
    3 years ago
  • Neutrophil to lymphocyte ratio and antidepressant treatment response in patients with major depressive disorder: Effect of sex and hippocampal volume
    Published on 2023-08-05
    3 years ago
  • The efficacy, safety, and adverse events of azapirones in anxiety disorders: A systematic review and meta-analysis of randomized controlled trials
    Published on 2023-08-05
    3 years ago
  • The Mechanism of Akathisia – Comments on Wu et al. Eur Neuropsychopharmacol 2023;72:40–49
    Published on 2023-07-26
    3 years ago
  • Measuring serum concentrations of psychotropics- Valuable tool for decision making or waste of money?
    Published on 2023-07-21
    3 years ago
  • A new approach to negative symptoms of schizophrenia
    Published on 2023-07-15
    3 years ago
  • Functional significance of dopamine release in the mesolimbic forebrain by modulation of adrenergic receptors
    Published on 2023-07-15
    3 years ago
« Previous 1 … 60 61 62 63 64 … 168 Next »

   Pharma Pub